REFERENCES
- [1] Andersson, T., Hassan-Alin, M., Hasselgren, G., Rohss., and K., Weidolf, L. 2001. Pharmacokinetic studies with esomeprazole, the (S)-Isomer of omeprazole. Clinical Pharmacokinetics, 40: 411-26.
- [2] Scott, L. J., Dunn, C. J., Mallarkey, G., and Sharpe, M. 2002. Esomeprazole-A review of its use in the management of acid-related disorders. Drugs, 62: 1503-38.
- [3] Press, Merck & Co., Inc. Budavari, S. 2001. “The Merck Index”, 13th Ed., Whitehouse Station, NJ, 3476.
- [4] Castro, D., Moreno, M. A., Torrado, S., and Lastres, J. L. 1999. Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of omeprazole in aqueous solution during stability studies. Journal of Pharmaceutical and Biomedical Analysis, 21: 291-08.
- [5] Ding, L., Yang, J., Yan, H. L., Zhang, Z. X., and An, D. K. 1999. Determination of omeprazole and its pharmacokinetics in human plasma by an improved HPLC method. Chinese Journal of Pharmaceutical Analysis, 17: 458-461.
- [6] Hassan-Alin, M., Andersson, T., Bredberg, E., and Rohss, K. 2000. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. European Journal of Clinical Pharmacology, 56- 1: 665-670.
- [7] Johnson, D. A., Roach, A. C., Carlsson, A. S., Karlsson, A. A., and Behr, D. E. 2003. Stability of esomeprazole capsule contents after in vitro suspension in common soft foods and beverages. Pharmacotherapy, 23: 731-4.
- [8] Li, X. Q., Anderson, T. B., Ahlstrom, M., and Weidolf, L. 2004. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metabolism Dispos, 32: 821-7.
- [9] Nafisur, R., Zehra, B., and Syed, N. 2008. Spectrophotometric determination of esomeprazole magnesium in commercial tablets using 5-sulfosalicylic acid and N-bromosuccinimide. Journal of Chinese Chemistry Society, 55: 557-566.
- [10] Shetty, R., Subramanian, G., Ranjith Kumar, A., Pandey, S., and Udupa, N. 2005. Estimation of esomeprazole in human plasma by reverse phase high performance liquid chromatography. Indian Drugs, 42: 158-61.
- [11] Al-Khamis, K. L., Hagga, M. E., and Al–Khamis, H. A. 1990. Spectrophotometric determination of domperidone using absorbance difference method. Analytical Letters, 23: 451-60.
- [12] Ramamohan, Y., and Avadhanulu, A. B. 1998. Extractive spectrophotometric determination of domperidone in its pharmaceutical dosage forms. Indian Drugs, 35: 754-6.
- [13] Yamamoto, K., Hagino, M., Kotaki, H., and Iga I. 1998. Quantitative determination of domperidone in rat plasma by high performance liquid chromatography with fluorescence detection. Journal of Chromatography Biomedical Applied Science, 720: 252-5.
- [14] Argekar, A. P. and Shah, S. J. 1999. Simultaneous determination of cinnarizine and domperidone maleate from tablet dosage form by reverse phase ion pair high performance liquid chromatography. Journal of Pharmaceutical Biomedical Analysis, 19: 813-17.
- [15] Zarapkar, SS. and Kanyawar, NS. 2002. Simultaneous estimation of domperidone and omeprazole in pharmaceutical dosage by reverse phase high performance liquid chromatography. Indian Drugs, 39: 217-21.
- [16] Bhavesh, P., Madhabhai, P., Jignesh, P., and Bhanubhai, S. 2007. HPLC analysis for simultaneous determination of rabeprazole and domperidone in pharmaceutical formulation. Journal of Liquid Chromatography & Related Technologies, 30: 43-445.
- [17] Priti, T. and Dilip, M. 2010. Estimation of esomeprazole and domperidone by absorption ratio method in pharmaceutical dosage forms. International Journal of Chemtech Research, 2: 1598-1605.